Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

Overview of attention for article published in BMC Cancer, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter: 1 X user

patent: 3 patents

Readers on

mendeley: 13 Mendeley

Summary X Patents

So far, Altmetric has seen 3 patents that reference this research output.

Subtyping prostate cancer to predict response to hormone therapy

Grant US-11873532-B2

United States of America

Use of genomic signatures to predict responsiveness of patients with prostate cancer to…

Grant US-11414708-B2

United States of America

USE OF IMMUNE CELL-SPECIFIC GENE EXPRESSION FOR PROGNOSIS OF PROSTATE CANCER AND…

Application EP-3662082-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.